Navigation Links
A connection between gingival enlargement and steroid abuse

Chicago – The extended use of anabolic androgenic steroid (AAS) is linked to gingival enlargement, according to researchers. // Gingival enlargement occurs when the tissues swell and begin to grow over the teeth. This is a fertile environment for bacteria to grow, which can lead to periodontal infection.

'It was found that AAS abusers had statistically significant levels of gingival enlargement compared to non-users, requiring a gingivectomy for many cases,' explains Onur Ozcelik, DDS, PhD, Faculty of Dentistry, Cukurova University, Department of Periodontology, Adana, Turkey. 'Although it has been reported that many of the adverse effects of AAS abuse are fully reversible within several months after the cessation of the drug, it is not known if gingival enlargement would also regress after the withdrawal of AAS.'

Researcher also found that gingival inflammation was higher in the AAS user group compared to the non-AAS users. 'Further studies are required to find out if increased gingival scores in the user group are a direct effect of AAS or if the inflammation is a result of compromised oral hygiene due to gingival enlargement,' said Ozcelik.

'It is not surprising that gingival tissue is a target for the actions of steroid hormones,' said Kenneth A. Krebs, DMD and AAP president. 'Clinical changes in tissues of the periodontium have been identified during periods of hormonal fluctuations such as puberty, the menstrual cycle, pregnancy, menopause, contraceptives and ovulation induction drugs in women.'People taking AAS without medical supervision should be informed of the adverse effects and strongly encouraged to begin a cessation program.

Since periodontal infection may be a risk factor for more serious conditions, such as cardiovascular disease, respiratory disease and pre-term, low birth weight babies it is important for patients to take care of their periodontal health.

This study is published in the Jour
'"/>




Page: 1 2

Related medicine news :

1. The mouth-heart connection
2. The mouth-heart connection
3. Processed Meat, Diabetes connection Found
4. No connection between breast cancer and pill
5. No connection between epidurals and backache
6. Virus connection to cervical injury
7. Stroke Risk and Fish :A factual interconnection
8. New technology to decipher neural connections dealing with heredity and environment
9. A connection Between Cry Babies and Postpartum Depression
10. The connection between strokes and the internal clock
11. The connection between socioeconomic status and risk of stroke
Post Your Comments:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
... survey, biting a bar of chocolate every day is co...h chocolates are high in fat and sugar, it has lon..., recent evidence suggests that, like other plant ...xidants, which can protect from chronic disease. ...
...tudy which suggests hormone suppression therapy co...ncer patient's chances of living free of the disea...y Hospital, examined the potential benefits of sup...e more commonly known male hormone testosterone, a...
... amount of fluids should be taken, in order to rep...er is far better than 'energy' drinks for keeping ...is maximum need for fluids,// henceforth, you'll b...ls topped up with regular drinks. There are a lot ...
...ch are protective substances, produced by the body...m kill the TB bacteria, researchers in the UK repo... journal Nature Medicine,// these heat-shock prote...body help cells survive stressful times and bolste...
Other Medicine News:Health News:Hormone Therapy applicable for Prostate Cancer 2
(Date:5/21/2008)...ark Laboratories, L.C., a,privately-owned biopharm...of enrollment into its Phase II clinical trial to ...n combination with standard of care therapy in,U.S... have previously,failed to respond to the standard...e company expects to announce interim data results...
(Date:5/21/2008)...oup of Leading Cancer Centers ...y 21 /- Endocare, Inc.,(Nas... focused on the,development of minimally invasive ... radiologists for tissue and tumor ablation, annou... method of freezing cancerous tumors,to destroy th...
(Date:5/20/2008)...positive results of nine month,PAINT trials for Dr...esults unveiled during plenary session of Eu...wswire/ -- Sahajanand Medical Technologies,Pvt. Lt...facturer of,drug-eluting stents, welcomed the posi...onths results of PAINT trial (PercutAneous INTerve...
(Date:5/20/2008)...igestive Disease Week -, CAMBRIDGE, Mass. and NEW...harmaceuticals, Inc. (formerly Microbia, Inc.) and...ounced the presentation of data,from a Phase 2b ra...ssessing the safety and efficacy of linaclotide in... of these data indicate that linaclotide met its,p...
Breaking Medicine Technology:Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 2Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 2Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 4Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6Secondhand smoke increases teen test failure 1648 1Secondhand smoke increases teen test failure 1648 2Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 1Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 1Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 3MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 1MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 2MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 3
...ylene Glycol,(DEG) Remains a Potential Health Haza...he U.S. Food and Drug,Administration (FDA) is warn...repackers, and health professionals who compound,m...hat glycerin, a,sweetener commonly used worldwide ...roducts, is not contaminated with diethylene,glyco...
...nnovations and a Health Conscious,Public?, WASHING... Food,and Drug Administration (FDA) must adapt to ...lthcare, Commissioner Andrew von,Eschenbach told a...,Annual Conference April 12 in Bethesda, Md. , FDA...ited,financial and personnel resources to deal wit...
Other Medicine Technology:FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
Cushing bayonet forceps. Insulated.
Scleral blades designed for trabeculectomy and groove type incisions, scleral standard USA size.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile
Medicine Products: